SEC 13F Intelligence

Versant Venture Management, LLC / CTNM

Versant Venture Management, LLC’s Contineum Therapeutics Inc Position

Does Versant Venture Management, LLC own Contineum Therapeutics Inc (CTNM)? Yes — 542.6K shares worth $7M (+5.01% of its 13F portfolio) as of Q1 2026.

Position Value
$7M
Q1 2026
Shares
542.6K
% of Portfolio
+5.01%
Quarters Held
8
currently held

Position History CTNM

Reported value by quarter
Q2 ’24: $16MQ2 ’24Q3 ’24: $18MQ3 ’24Q4 ’24: $13MQ4 ’24Q1 ’25: $6MQ1 ’25Q2 ’25: $2MQ2 ’25Q3 ’25: $6MQ3 ’25Q4 ’25: $6MQ4 ’25Q1 ’26: $7MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026542.6K$7M+5.01%
Q4 2025542.6K$6M+4.11%
Q3 2025542.6K$6M+3.00%
Q2 2025542.6K$2M+2.62%
Q1 2025918.2K$6M+10.64%
Q4 2024918.2K$13M+15.51%
Q3 2024918.2K$18M+27.64%
Q2 2024918.2K$16M+20.92%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Versant Venture Management, LLC’s full portfolio or all institutional holders of CTNM.